(Q45870261)

17 December 2017

title

A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma (English)

1 reference

17 December 2017

0 references

1 reference

Nishikubo K

1

1 reference

17 December 2017

Murata Y

2

1 reference

17 December 2017

Tamaki S

3

1 reference

17 December 2017

Sugama K

4

1 reference

17 December 2017

Imanaka-Yoshida K

5

1 reference

17 December 2017

Yuda N

6

1 reference

17 December 2017

Kai M

7

1 reference

17 December 2017

Takamura S

8

1 reference

17 December 2017

Sebald W

9

1 reference

17 December 2017

Adachi Y

10

1 reference

17 December 2017

Yasutomi Y

11

1 reference

17 December 2017

publication date

1 December 2003

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

26

1 reference

17 December 2017

page(s)

2119-2125

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302131

exact match

0 references

cites work

TH1 and TH2 CD4+ cells in human allergic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

The inverse association between tuberculin responses and atopic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Sorting out the cytokines of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

The IL-4 receptor: signaling mechanisms and biologic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

21 January 2018

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

The toxicology of interleukin-12: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis in DBA/1 J suckling mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Eosinophilopoiesis in A Murine Model of Allergic Airway Eosinophilia: Involvement of Bone Marrow IL-5 and IL-5 Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Asthma: an epidemic in the absence of infection?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Human blood eosinophils produce and secrete interleukin 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Interleukin-4 is required for the induction of lung Th2 mucosal immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

The Interleukin-4-Receptor: From Recognition Mechanism to Pharmacological Target Structure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Administration of interleukin-12 exerts a therapeutic instead of a long-term preventive effect on mite Der p I allergen-induced animal model of airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Inhibitory effects of endogenous and exogenous interferon-gamma on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Treatment of steroid-dependent asthma with recombinant interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Anti-interleukin-4 inhibits immunoglobulin E production in a murine model of atopic asthma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302131

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302131

1 reference

17 December 2017

Dimensions Publication ID

1030513233

0 references

Fatcat ID

release_kakmfiqgpnexjaxn6nqebx4qyy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kakmfiqgpnexjaxn6nqebx4qyy

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017